Atlas Trials

Daclatasvir, Asunaprevir Plus Ribavirin for HCV Genotype 1b Without NS5A RAV

Clinical trial NCT03004625 · COMPLETED

Trial details

NCT number
NCT03004625
Sponsor
Kaohsiung Medical University Chung-Ho Memorial Hospital
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Hepatitis C
Start date
2016-11-01
Primary completion
2018-04-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.